Logo image of SABE.PA

SAINT JEAN GROUPE SA (SABE.PA) Stock Fundamental Analysis

EPA:SABE - Euronext Paris - Matif - FR0000060121 - Common Stock - Currency: EUR

19.8  +0.9 (+4.76%)

Fundamental Rating

3

Taking everything into account, SABE scores 3 out of 10 in our fundamental rating. SABE was compared to 56 industry peers in the Food Products industry. SABE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. SABE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year SABE was profitable.
In the past year SABE had a positive cash flow from operations.
In the past 5 years SABE has always been profitable.
Each year in the past 5 years SABE had a positive operating cash flow.
SABE.PA Yearly Net Income VS EBIT VS OCF VS FCFSABE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

SABE has a worse Return On Assets (1.21%) than 66.07% of its industry peers.
SABE's Return On Equity of 2.64% is on the low side compared to the rest of the industry. SABE is outperformed by 64.29% of its industry peers.
The Return On Invested Capital of SABE (0.74%) is worse than 75.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SABE is significantly below the industry average of 6.33%.
Industry RankSector Rank
ROA 1.21%
ROE 2.64%
ROIC 0.74%
ROA(3y)1.32%
ROA(5y)1.25%
ROE(3y)3.01%
ROE(5y)2.68%
ROIC(3y)1.23%
ROIC(5y)1.21%
SABE.PA Yearly ROA, ROE, ROICSABE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

SABE has a Profit Margin (1.72%) which is in line with its industry peers.
SABE's Profit Margin has declined in the last couple of years.
The Operating Margin of SABE (1.18%) is worse than 73.21% of its industry peers.
In the last couple of years the Operating Margin of SABE has declined.
SABE has a Gross Margin of 35.13%. This is comparable to the rest of the industry: SABE outperforms 44.64% of its industry peers.
SABE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.18%
PM (TTM) 1.72%
GM 35.13%
OM growth 3Y-18.97%
OM growth 5Y-12.42%
PM growth 3Y-4.9%
PM growth 5Y-18.34%
GM growth 3Y-0.46%
GM growth 5Y-1.77%
SABE.PA Yearly Profit, Operating, Gross MarginsSABE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

5

2. Health

2.1 Basic Checks

SABE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for SABE remains at a similar level compared to 1 year ago.
The number of shares outstanding for SABE has been reduced compared to 5 years ago.
Compared to 1 year ago, SABE has an improved debt to assets ratio.
SABE.PA Yearly Shares OutstandingSABE.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
SABE.PA Yearly Total Debt VS Total AssetsSABE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

SABE has an Altman-Z score of 1.99. This is not the best score and indicates that SABE is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.99, SABE is in line with its industry, outperforming 50.00% of the companies in the same industry.
SABE has a Debt/Equity ratio of 0.66. This is a neutral value indicating SABE is somewhat dependend on debt financing.
SABE has a Debt to Equity ratio (0.66) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF N/A
Altman-Z 1.99
ROIC/WACC0.13
WACC5.85%
SABE.PA Yearly LT Debt VS Equity VS FCFSABE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 2.04 indicates that SABE has no problem at all paying its short term obligations.
SABE has a Current ratio of 2.04. This is in the better half of the industry: SABE outperforms 76.79% of its industry peers.
SABE has a Quick Ratio of 1.70. This is a normal value and indicates that SABE is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of SABE (1.70) is better than 83.93% of its industry peers.
Industry RankSector Rank
Current Ratio 2.04
Quick Ratio 1.7
SABE.PA Yearly Current Assets VS Current LiabilitesSABE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

1

3. Growth

3.1 Past

SABE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -52.15%.
SABE shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -11.41% yearly.
Looking at the last year, SABE shows a small growth in Revenue. The Revenue has grown by 1.02% in the last year.
SABE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.46% yearly.
EPS 1Y (TTM)-52.15%
EPS 3Y3.48%
EPS 5Y-11.41%
EPS Q2Q%-84.15%
Revenue 1Y (TTM)1.02%
Revenue growth 3Y7.11%
Revenue growth 5Y7.46%
Sales Q2Q%1.68%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SABE.PA Yearly Revenue VS EstimatesSABE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

SABE is valuated quite expensively with a Price/Earnings ratio of 31.43.
Compared to the rest of the industry, the Price/Earnings ratio of SABE is on the same level as its industry peers.
SABE is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.52, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 31.43
Fwd PE N/A
SABE.PA Price Earnings VS Forward Price EarningsSABE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

SABE's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. SABE is cheaper than 69.64% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7
SABE.PA Per share dataSABE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SABE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SAINT JEAN GROUPE SA

EPA:SABE (6/3/2025, 7:00:00 PM)

19.8

+0.9 (+4.76%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners12.41%
Ins Owner ChangeN/A
Market Cap63.36M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.1
Dividend Growth(5Y)-14.7%
DP15.81%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 31.43
Fwd PE N/A
P/S 0.54
P/FCF N/A
P/OCF 5.95
P/B 0.83
P/tB 0.91
EV/EBITDA 7
EPS(TTM)0.63
EY3.18%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.9
FCFYN/A
OCF(TTM)3.33
OCFY16.8%
SpS36.51
BVpS23.83
TBVpS21.86
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.21%
ROE 2.64%
ROCE 1.01%
ROIC 0.74%
ROICexc 0.99%
ROICexgc 1.05%
OM 1.18%
PM (TTM) 1.72%
GM 35.13%
FCFM N/A
ROA(3y)1.32%
ROA(5y)1.25%
ROE(3y)3.01%
ROE(5y)2.68%
ROIC(3y)1.23%
ROIC(5y)1.21%
ROICexc(3y)1.73%
ROICexc(5y)1.82%
ROICexgc(3y)1.85%
ROICexgc(5y)1.97%
ROCE(3y)1.67%
ROCE(5y)1.64%
ROICexcg growth 3Y-22.35%
ROICexcg growth 5Y-20.1%
ROICexc growth 3Y-21.76%
ROICexc growth 5Y-18.9%
OM growth 3Y-18.97%
OM growth 5Y-12.42%
PM growth 3Y-4.9%
PM growth 5Y-18.34%
GM growth 3Y-0.46%
GM growth 5Y-1.77%
F-Score7
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF N/A
Debt/EBITDA 3.97
Cap/Depr 120.52%
Cap/Sales 11.59%
Interest Coverage 250
Cash Conversion 84.42%
Profit Quality N/A
Current Ratio 2.04
Quick Ratio 1.7
Altman-Z 1.99
F-Score7
WACC5.85%
ROIC/WACC0.13
Cap/Depr(3y)230.83%
Cap/Depr(5y)238.47%
Cap/Sales(3y)16.15%
Cap/Sales(5y)16.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-52.15%
EPS 3Y3.48%
EPS 5Y-11.41%
EPS Q2Q%-84.15%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.02%
Revenue growth 3Y7.11%
Revenue growth 5Y7.46%
Sales Q2Q%1.68%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-71.87%
EBIT growth 3Y-13.22%
EBIT growth 5Y-5.88%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y56.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-0.88%
OCF growth 3Y8.5%
OCF growth 5Y8.59%